Diurnal is proud to support the University of Glasgow in setting up the I-CAH network and registry.
The I-CAH network is an initiative to improve the clinical management of the rare disease Congenital Adrenal Hyperplasia (CAH).
Its purpose is to provide information and resources for both physicians, and patients and their families, and to act as a portal to the newly created I-CAH Registry.
The I-CAH Registry is the centerpiece of the I-CAH network and has been created in order to connect clinical and research centres around the world, within a virtual research environment. The goal is to facilitate and underpin research into new management strategies and therapies in the treatment of Congenital Adrenal Hyperplasia, to allow physicians to optimize the care of patients with this rare disease.
The I-CAH network would therefore encourage physicians to enrol their patients in the I-CAH Registry and participate in research.
Visit the I-CAH website for more information.